Sign up
Quantellect · Congress · Trade Detail
CMBSiShares CMBS Bond ETF (CMBS) F ILINg S TaTUS : amended S UBHoLDINg o F : UBS Brokerage account
RepublicanHouse

Carlos Curbelo bought iShares CMBS Bond ETF (CMBS) F ILINg S TaTUS : amended S UBHoLDINg o F : UBS Brokerage account (CMBS)

Carlos Curbelo (R-FL), a U.S. Representative, has disclosed 8 trades in iShares CMBS Bond ETF (CMBS) F ILINg S TaTUS : amended S UBHoLDINg o F : UBS Brokerage account (CMBS) since 2015, 5 purchases and 3 sales, worth an estimated $64K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Carlos Curbelo bought $1,001 - $15,000 of iShares CMBS Bond ETF (CMBS) F ILINg S TaTUS : amended S UBHoLDINg o F : UBS Brokerage account (CMBS) on March 9, 2016. Since that trade, CMBS is up +24.54% against the S&P 500 up +332.87%, an outperformance of -308.32%.

Across these filings, Carlos Curbelo has been a net buyer of CMBS (a buy-to-sell ratio of 1.67). The most recent disclosed CMBS transaction shown was dated April 5, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

CMBS trades
8
Disclosed Vol
$64K
Buys
5
63%
Sells
3
38%
Buy / Sell
1.67
ratio
First → Last
2015–2017

Carlos Curbelo's CMBS trades vs the price

CMBS is up +24.54% since Carlos Curbelo bought on March 9, 2016, versus +332.87% for the S&P 500.

Performance since this trade

Price change since trade
+24.54%
S&P 500 change since trade
+332.87%
Outperformance vs S&P 500
-308.32%

All Carlos Curbelo CMBS trades

TradedTypeSizeReturnEst. profit
April 5, 2017SELL$39.49+22.18%
July 22, 2016BUY$40.14+20.20%-$709
May 25, 2016SELL$39.46+22.27%
March 9, 2016BUY$38.74+24.54%-$502
March 9, 2016BUY$38.74+24.54%-$502
October 23, 2015BUY$38.40+25.65%-$510
July 14, 2015BUY$38.07+26.74%-$488
April 17, 2015SELL$38.56+25.14%

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Carlos Curbelo & CMBS trading FAQ

Is it legal for Carlos Curbelo to trade iShares CMBS Bond ETF (CMBS) F ILINg S TaTUS : amended S UBHoLDINg o F : UBS Brokerage account (CMBS) stock?

Yes. Members of Congress are allowed to trade individual stocks, including iShares CMBS Bond ETF (CMBS) F ILINg S TaTUS : amended S UBHoLDINg o F : UBS Brokerage account (CMBS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Carlos Curbelo buy CMBS?

Carlos Curbelo disclosed a purchase of $1,001 - $15,000 of iShares CMBS Bond ETF (CMBS) F ILINg S TaTUS : amended S UBHoLDINg o F : UBS Brokerage account (CMBS) on March 9, 2016, according to public STOCK Act filings.

How has CMBS performed since Carlos Curbelo's trade?

Since Carlos Curbelo bought CMBS on March 9, 2016, the stock is up +24.54%, versus +332.87% for the S&P 500 over the same period, an outperformance of -308.32%.

How many times has Carlos Curbelo traded CMBS?

Carlos Curbelo has disclosed 8 CMBS trades since 2015 (5 purchases and 3 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional CMBS trades?

Quantellect tracks every disclosed congressional trade in iShares CMBS Bond ETF (CMBS) F ILINg S TaTUS : amended S UBHoLDINg o F : UBS Brokerage account (CMBS) on the iShares CMBS Bond ETF (CMBS) F ILINg S TaTUS : amended S UBHoLDINg o F : UBS Brokerage account congressional trading page, which aggregates filings across all members of Congress.

Carlos Curbelo's CMBS tradesAll congressional filings for iShares CMBS Bond ETF (CMBS) F ILINg S TaTUS : amended S UBHoLDINg o F : UBS Brokerage accountCarlos Curbelo's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.